Brief: Castle Biosciences Sees FY Rev $255 Mln To $330 Mln
20/09/2022 21:13
Sept 20 (Reuters) - Castle Biosciences Inc CSTL.O :
* CASTLE BIOSCIENCES INC SEES FY REVENUE $255.0 MILLION TO
$330.0
MILLION
* CASTLE BIOSCIENCES INC - ANTICIPATED REVENUE OF $255-$330
MILLION AND ANTICIPATED NET OPERATING CASH FLOW POSITIVITY FOR
YEAR ENDING DECEMBER 31, 2025
Source text for Eikon: ID:nBw66MBqza
Further company coverage: CSTL.O
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million